Retractable Technologies Inc (RVP)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$0.71-0.43%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · RVP
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. On June 30, 2026, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On March 27, 2026, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing results for 2025. On March 27, 2026, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On December 30, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On September 30, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On June 30, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Changes in Registrant’s Certifying Accountant. On June 2, 2025, Retractable Technologies Inc. (the “Company”) was notified that Moss Adams LLP (“Moss Adams”), the Company’s independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Comp…
Other Events. On May19, 2025, Retractable Technologies, Inc. (the “Company”) entered into a Settlement Agreement resolving all claims and causes in action in Cause No. DC-19-17946, Retractable Technologies, Inc. v. Locke Lord LLP, et al. , in the 44th District Court of Dallas County, Texas (the “Lawsuit”). The Lawsuit had alleged various claims in connection with legal representation of the Company in its previous litigation against Becton, Dickinson and Company. Neither the Company nor the d…
Other Events. On April 10, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing a reduction in workforce.
Other Events. On March 28, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing results for 2024. On March 28, 2025, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On December 30, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On September 20, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing that the Office of the United States Trade Representative issued final adjustments to tariffs on Chinese imported syringes and needles. On September 30, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing that the Company filed a complaint related to the recent tariffs in the U.S. Court…
Other Events. On June 28, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On March 29, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing results for 2023. On March 29, 2024, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On December 29, 2023, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On September 29, 2023, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On June 30, 2023, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On March 30, 2023, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing results for 2022. On March 31, 2023, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Other Events. On March 22, 2023, the Company implemented a workforce reduction. The related press release dated March 27, 2023 is attached as Exhibit 99.
Entry into a Material Definitive Agreement. On December 27, 2022, the Company entered into a stock repurchase agreement with BML Investment Partners, L.P. to repurchase 3 million shares of the Company’s common stock for $1.60 per share in a private transaction. The aggregate purchase price is $4.8 million. The closing date is December 29, 2022. The stock repurchase agreement contains customary representations, warranties, and covenants of the parties. The foregoing description of the stock re…
Other Events. On December 28, 2022, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders. On December 29, 2022, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing that it had agreed to repurchase 3 million shares in a private transaction.
The filing pertains to the termination of unvested stock option awards, not a management change.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.